Sildenafil (Viagra) is a vasodilator mainly used in the treatment of erectile dysfunction. Atrial or ventricular fibrillation may rarely occur as a side effect during sildenafil therapy. Although changes in inward rectifier potassium currents including IK1 are known to contribute to the pathogenesis of fibrillation, the effect of sildenafil on IK1 has not been studied. In experiments, Ba2+ is used as a specific inhibitor of IK1 at high concentrations (usually 100 μM). Being an environmental contaminant, it is also present in the human body; Ba2+ plasmatic concentrations up to 1.5 μM are usually reported in the general population. This study was primarily aimed to investigate changes of IK1 induced by sildenafil in a wide range of concentrations (0.1-100 μM). Additionally, the effect of combination of sildenafil and Ba2+ at selected clinically-relevant concentrations was tested, at 0.1 μM both on IK1 and on the action potential duration (APD). Experiments were performed by the whole-cell patch-clamp technique on enzymatically isolated rat ventricular cardiomyocytes, mostly at 23°C with the exception of APD measurements which were performed at 37°C as well. Sildenafil caused a significant, reversible, and concentration-dependent inhibition of IK1 that did not differ at -50 and -110 mV. Simultaneous application of sildenafil and Ba2+ at 0.1 μM revealed a massive inhibition of both inward and outward components of IK1 (this synergy was missing at other tested combinations). The combined effect at 0.1 μM (45.7 ± 5.7 and 43.0 ± 6.9% inhibition at -50 and -110 mV, respectively) was significantly higher than a simple sum of almost negligible effects of the individual substances and it led to a significant prolongation of APD at both 23 and 37°C. To our knowledge, similar potentiation of the drug-channel interaction has not been described. The observed massive inhibition of IK1 induced by a combined action of the vasodilator sildenafil and environmental contaminant Ba2+ at a low concentration and resulting in a significant APD prolongation may contribute to the genesis of arrhythmias observed in some patients treated with sildenafil.

Department of Physiology Faculty of Medicine Masaryk University Brno Czechia

000      

00000naa a2200000 a 4500

001      

bmc22017313

003      

CZ-PrNML

005      

20230518100937.0

007      

ta

008      

220718s2022 sz f 000 0|eng||

009      

AR

024    7_

$a 10.3389/fphar.2022.829952 $2 doi

035    __

$a (PubMed)35548367

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a sz

100    1_

$a Macháček, Martin $u Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czechia $7 xx0282244

245    10

$a Combination of Sildenafil and Ba2+ at a Low Concentration Show a Significant Synergistic Inhibition of Inward Rectifier Potassium Current Resulting in Action Potential Prolongation / $c M. Macháček, O. Švecová, M. Bébarová

520    9_

$a Sildenafil (Viagra) is a vasodilator mainly used in the treatment of erectile dysfunction. Atrial or ventricular fibrillation may rarely occur as a side effect during sildenafil therapy. Although changes in inward rectifier potassium currents including IK1 are known to contribute to the pathogenesis of fibrillation, the effect of sildenafil on IK1 has not been studied. In experiments, Ba2+ is used as a specific inhibitor of IK1 at high concentrations (usually 100 μM). Being an environmental contaminant, it is also present in the human body; Ba2+ plasmatic concentrations up to 1.5 μM are usually reported in the general population. This study was primarily aimed to investigate changes of IK1 induced by sildenafil in a wide range of concentrations (0.1-100 μM). Additionally, the effect of combination of sildenafil and Ba2+ at selected clinically-relevant concentrations was tested, at 0.1 μM both on IK1 and on the action potential duration (APD). Experiments were performed by the whole-cell patch-clamp technique on enzymatically isolated rat ventricular cardiomyocytes, mostly at 23°C with the exception of APD measurements which were performed at 37°C as well. Sildenafil caused a significant, reversible, and concentration-dependent inhibition of IK1 that did not differ at -50 and -110 mV. Simultaneous application of sildenafil and Ba2+ at 0.1 μM revealed a massive inhibition of both inward and outward components of IK1 (this synergy was missing at other tested combinations). The combined effect at 0.1 μM (45.7 ± 5.7 and 43.0 ± 6.9% inhibition at -50 and -110 mV, respectively) was significantly higher than a simple sum of almost negligible effects of the individual substances and it led to a significant prolongation of APD at both 23 and 37°C. To our knowledge, similar potentiation of the drug-channel interaction has not been described. The observed massive inhibition of IK1 induced by a combined action of the vasodilator sildenafil and environmental contaminant Ba2+ at a low concentration and resulting in a significant APD prolongation may contribute to the genesis of arrhythmias observed in some patients treated with sildenafil.

655    _2

$a časopisecké články $7 D016428

700    1_

$a Švecová, Olga $u Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czechia $7 xx0301708

700    1_

$a Bébarová, Markéta $u Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czechia

773    0_

$w MED00174597 $t Frontiers in pharmacology $x 1663-9812 $g Roč. 13, č. - (2022), s. 829952

856    41

$u https://pubmed.ncbi.nlm.nih.gov/35548367 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y - $z 0

990    __

$a 20220718 $b ABA008

991    __

$a 20230518100931 $b ABA008

999    __

$a ind $b bmc $g 1816535 $s 1168555

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2022 $b 13 $c - $d 829952 $e 20220425 $i 1663-9812 $m Frontiers in pharmacology $n Front Pharmacol $x MED00174597

LZP    __

$a Pubmed-20220718